• 제목/요약/키워드: Respiratory infections

검색결과 582건 처리시간 0.036초

Pasteurella multocida의 외막 단백질 H에 의해 유도되는 방어적 항체와 면역 (Protective Antibodies and Immunity elicited by Immunization with Outer Membrane Protein H of Pasteurella multocida in Mice)

  • 권무식;김영봉;이정민
    • 미생물학회지
    • /
    • 제43권1호
    • /
    • pp.7-13
    • /
    • 2007
  • Pasteurella multocida는 돼지에서 위축성 비염, 폐렴을 비롯한 다양한 호흡기 질환을 일으키는 병원균이다. 본 연구에서는 돼지 위축성 비염에 대한 효과적인 순수정제 백신을 개발하고자 하는 기초 연구로서 P. multocida의 외막 단백질 H에 의해 유도되는 방어적 항체와 면역을 확인하였다. P. multocida의 외막 단백질을 포함하는 분획은 호흡기 질병 혼합 백신에 대한 항혈청과 불활화된 사균 세포에 대한 항혈청 모두에서 면역학적으로 검출 가능하였다. 선행 연구에서 분리한 외막 단백질 H 유전자는 재조합 발현 백터 제작에 이용되어 대장균으로부터 재조합 외막단백질 H를 정제하였다. 실험 동물 면역과 항혈청의 교차반응, ELISA를 통한 항체 역가의 측정 및 공격접종을 통하여, 재조합 외막 단백질 H는 높은항원성을 가지며, 지속적인 체액성 면역을 유도하는 것을 확인하였다. 외막 단백질 H는 순수정제 항원으로서 P. multocida에 의한 호흡기 질환에 대한 효과적인 방어를 유도할 수 있는 단위 백신 후보 단백질로 여겨진다.

뇌경색 발병후 병발된 만성 애역(Chronic hiccup)의 뜸치료 1례 (A Case of Moxibustion Therapy on Chronic Hiccups after Cerebral Infarction)

  • 전우현;김진석;홍종희;홍상선;박석규;김진성;류봉하;류기원;박재우
    • 대한한방내과학회지
    • /
    • 제22권1호
    • /
    • pp.109-112
    • /
    • 2001
  • Hiccups, also known as singultus, are spasmodic involuntary contractions of respiratory muscles that shorten respiration. The characteristic sound is caused by rapid closure of the glottis. In oriental medicine, the mechanism of hiccups is "reversed flow of Ki". Hiccups have been associated with neoplasm, infections, seizures, diabetes. renal failure, alcohol ingestion, various drugs, and ischemic events of the myocardium or central nervous system. We present a case of chronic hiccups after cerebral infarction that was successfully treated using moxibustion therapy.

  • PDF

Enterovirus 71 infection: An experience in Korea, 2009

  • Kim, Kyung-Hyo
    • Clinical and Experimental Pediatrics
    • /
    • 제53권5호
    • /
    • pp.616-622
    • /
    • 2010
  • Enterovirus 71 (EV71) has been recognized as a frequent cause of epidemics of hand-foot-and-mouth disease (HFMD) associated with severe neurological symptoms. In the spring of 2009, HFMD was epidemic in Korea. Severe cases with complication, including death, have been reported and it has become a public health issue. Most symptomatic EV71 infections commonly result in HFMD or herpangina. These clinical manifestations can be associated with neurologic syndromes frequently. Neurologic syndromes observed in EV71 include meningitis, meningoencephalomyelitis, poliomyelitis-like paralytic disease, Guillain-Barr$\acute{e}$ syndrome, transverse myelitis, cerebellar ataxia, opsoclonus-myoclonus syndrome, benign intracranial hypertension, and brainstem encephalitis. Examinations for EV 71 were performed from the stools, respiratory secretion or CSF of the children by realtime PCR. Gene analysis showed that most of them were caused by EV71 subgenotype C4a which was prevalent in China, 2008. Public health measures including personal and environmental hygiene, must to target daycare centers, kindergartens, and schools where highly susceptible children congregate. To prevent the spread of infection, preschools where transmission persists for more than 2 incubation periods, have been recommended for closure, and trigger criteria for voluntary closure was instituted. During closure, operators are to thoroughly clean the centers before they are allowed to reopen. In addition, parents are advised to ensure that their children adopt a high standard of personal hygiene and to keep the infected child at home until full recovery. Because the outbreaks occur in a cyclical pattern, surveillance system to predict next outbreaks and adequate public health measures to control need to be planned for future. Control of EV71 epidemics through surveillance and public health intervention needs to be maintained in Korea. Future research should focus on understanding of EV71 virulence, identification of the receptor(s) for EV71, development of antiviral agents and development of vaccine.

조선시대(朝鮮時代) 현종(顯宗), 숙종(肅宗), 경종(景宗), 영조(英祖)의 질병(疾病)과 치료(治療) (About the Diseases and Medical Treatments of King Hyeonjong, Sukjong, Gyeongjong, Yeongjo in the Joseon Dynasty)

  • 이해웅;김훈
    • 대한한의학원전학회지
    • /
    • 제19권3호
    • /
    • pp.228-254
    • /
    • 2006
  • 1. King Hyeonjong(1641-1674) mainly suffered from eye disease and abscess. He specially took a hot spring bath for cure of eye and skin problems. He probably died of septicemia and the following gastro-intestinal infection at the age of 34, quite early for his age. 2. King Sukjong(1661-1720) was not very well all through his life, but lived quite longer than other Kings in the Joseon Dynasty. He suffered from various diseases like heart-based heat, abscess, edema, upper respiratory infections, etc. He frequently took the treatments of acupuncture and moxibustion. He presumably died of dysfunction of liver and kidney at the age of 60. 3. King Gyeongjong(1688-1724) suffered from political problems from birth to death, so he may have had excessive mental stress for his poor health. He mainly suffered from heart-based heat and abscess. It is quite not sure why he died in only one month from the onset of his symptoms, so many people thought that he was poisoned to death. He probably died of septicemia and the following gastro-intestinal infection at the age of 37. 4. King Yeongjo(1694-1776) lived for 83 years, which is the longest of all the Kings in the Joseon Dynasty. He mainly suffered from hypofunction of gastro-intestinal system with cold symptoms, coughs, uneasiness. He took various kinds of herbal medicine, of which he took ginseng the most. He is supposed to be dead due to his old age at 83.

  • PDF

Serologlcal survey of infections agents in domesticated boars

  • Cho, Kwang-Hyun;Park, In-Hwa;Kim, Young-Hoan;Kim, Soon-Tae;Kim, Sung-Kook;Park, No-Chan;Son, Jae-Kwon;Jyeong, Jong-Sik
    • 한국동물위생학회지
    • /
    • 제24권4호
    • /
    • pp.359-367
    • /
    • 2001
  • A serological survey was performed to establish basic data for the prevalence of antibodies to some major diseases of domesticated boar serum samples from January to December 2000. Sera collected in breeding farms in Gyeongbuk province were tested for Aujeszky's disease virus(ADV), Porcine reproductive and respiratory syndrome virus(PRRSV), Porcine parvovirus(PPV), Japanese encephalitis virus (JEV), Bordetella bronchiseptica(B bronchiseptica), Mycoplasma ; APP), Toxoplasma, and Brucella. There was no antibody to ADV in domesticated boars serum samples detected by Anti-ADV-gpI assay kit. Sero-positive samples to PRRS by IFA were 0.9%(3/330) The HI titers to PPV ranged variously from less than 10 to over 1,280. Two hundred ninety-four out of 330 tested sera showed HI titer of less than 10. In HI test to JEV, 90.3% of the sera (298/330) were below 10. The majority of the serum samples had low prevalence of the antibody B bronchiseptica. ELISA titers to M hyopneumoniae ranged variously from $\leq$ 10 to $\geq$ 1,280. Antibody titers to A pleuropneumoniae type 2(APP2) and type 5(APP5) were 58.2% and 52.7%, respectively, and the tested samples showing ELISA antibody titers of less than 20. There was no significant geographical difference between APP2 and APP5 in this study. In the antibody test of Toxoplasma, 11.5%(38/330) were positive and samples were all negative in sera test of Brucella.

  • PDF

A comparison of single dose efficacy of Mycoplasma hyopneumoniae bacterin in swine farms with different serological patterns of PRRSV and PCV2

  • Kim, Hye Kwon;Moon, Hyoung Joon;Kim, Eun Mi;Yang, Jeong Sun;Pakr, Seong Jun;Luo, Yuzi;Lee, Chul Seung;Song, Dae Sub;Kang, Bo Kyu;Lee, Jaebum;Park, Bong Kyun
    • 대한수의학회지
    • /
    • 제48권3호
    • /
    • pp.267-274
    • /
    • 2008
  • This study was to evaluate the efficacy of single dose Mycoplasma hyopneumoniae (M. hyo)-vaccination in the swine farms which had different serological patterns of porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2). A minimum of 240 pigs from each farm was applied, allocating M. hyo vaccinated and control groups. The PRRSV and PCV2 infections were analyzed by serological method (commercial ELISA kit). After administrating pigs a single dose of M. hyo vaccine or control saline at 3 weeks of age, serum antibodies to M. hyo, PRRSV and PCV2 were monitored at 4, 10, 16 and 22 weeks of age. Mortality, weight changes, feed conversion ratio (FCR) and lung score were also evaluated. A single-dose vaccination of M. hyo bacterin was efficacious to reduce mycoplasmal lung lesions and induce good humoral immune response. However, FCR was improved only in one of the three farms where showed seronegative status to both PRRSV and PCV2 in the period from 4 to 16 weeks of age. These results might imply that M. hyo vaccine alone could not overcome the PRRSV and PCV2 infection-associated wasting in the field condition. Therefore, the control of PRRSV and PCV2 should be considered to obtain the better effects of M. hyo vaccination.

환자 상태 정보를 활용한 메르스 치사율 추정법 (Estimation of the case fatality ratio of MERS epidemics using information on patients' severity condition)

  • 황선영;오창혁
    • Journal of the Korean Data and Information Science Society
    • /
    • 제27권3호
    • /
    • pp.599-607
    • /
    • 2016
  • 한국에서 새로운 유형의 메르스 코로나 바이러스 감염에 의한 중동 호흡기 증후군 환자가 처음으로 발생한 이후 급속하게 번져, 사회적으로 큰 문제가 되었다. 최근 중동의 아라비아 반도를 중심으로 처음으로 감염 환자가 발생한 이 질병은 사우디 아라비아에서의 치사율이 30~40%에 이르는 것으로 알려져 있다. 그러나 전염 과정 초기에 한국질병관리본부에서 발표하는 치사율은 10% 초반으로 기존에 알려져 있는 치사율에 비해 현저히 낮은 수준을 보였다. 이는 전염 진행 과정에서 사망 또는 퇴원하지 않고 입원 중인 메르스 확진 환자의 수를 고려하지 않은 확진자 중 사망자의 비율을 사용하는 단순추정법에 기인한 것이었다. 치사율은 그 값에 따라서 전염병의 대처 정책에 큰 영향을 미치는 값이므로 전염 과정의 초기부터 안정적으로 치사율을 추정하는 것이 중요하다. 따라서 본 연구에서는 기존의 추정치에 비해 감염의 초기 단계에서부터 안정적으로 치사율을 추정하는 방법을 제시한다. 제시된 추정치는 메르스로 인한 사망자 수 이외에 입원 환자의 상태의 정보를 활용하였다. 새로운 추정치의 성능을 보기 위하여 한국에서 발생한 감염 이후 2015년 8월 10일까지 186명의 감염자 자료를 사용하여 치사율을 추정하고 기존의 여러 가지 치사율 추정치와 비교하였다. 제시한 추정치는 감염의 초기 단계에서부터 다른 추정치에 비해 안정적인 모습을 보였다.

siRNA-mediated gene silencing of MexB from the MexA-MexB-OprM efflux pump in Pseudomonas aeruginosa

  • Gong, Feng-Yun;Zhang, Ding-Yu;Zhang, Jiang-Guo;Wang, Li-Li;Zhan, Wei-Li;Qi, Jun-Ying;Song, Jian-Xin
    • BMB Reports
    • /
    • 제47권4호
    • /
    • pp.203-208
    • /
    • 2014
  • To gain insights into the effect of MexB gene under the short interfering RNA (siRNA), we synthesized 21 bp siRNA duplexes against the MexB gene. RT-PCR was performed to determine whether the siRNA inhibited the expression of MexB mRNA. Changes in antibiotic susceptibility in response to siRNA were measured by the E-test method. The efficacy of siRNAs was determined in a murine model of chronic P. aeruginosa lung infection. MexB-siRNAs inhibited both mRNA expression and the activity of P. aeruginosa in vitro. In vivo, siRNA was effective in reducing the bacterial load in the model of chronic lung infection and the P. aeruginosa-induced pathological changes. MexB-siRNA treatment enhanced the production of inflammatory cytokines in the early infection stage (P < 0.05). Our results suggest that targeting of MexB with siRNA appears to be a novel strategy for treating P. aeruginosa infections.

소양인 형방패독산의 함염증효과에 대한 실험적 연구 (Study on the Anti-inflammatory Effects of Soyangin-Hyeongbangpaedok-san)

  • 허정원;강희;안광석;김성훈;최승훈;안규석;심범상
    • 동의생리병리학회지
    • /
    • 제23권2호
    • /
    • pp.443-451
    • /
    • 2009
  • Soyangin-Hyeongbangpaedok-san(SHBPDS) is used for treating upper respiratory infections, In an effort to investigate the anti-inflammatory effects of SHBPDS, we measured production of several cytokines and immunoglobulin in various immune cells. SHBPDS decreased the secretion of TNF-${\alpha}$, but not that of IL-6 in PMA/A23187 stimulated HMC-1 cells. As for mouse B cells, it induced proliferation and caused differential effects in expressions of surface IgE as determined by flow cytometry and secretions of IgE, IgG1, ILA and INF-${\gamma}$as measured by ELISA but showed little change in CD23 or CD69 expression. SHBPDS increased proliferation in anti-CD3/anti-CD28 stimulated CD4 Th cells. Under the Th1/Th2 polarization conditions, SHBPDS at 200 ${\mu}g/m{\ell}$ suppressed the secretion of INF-${\gamma}$ and IL-4. Based on the above results, we conclude that SHBPDS has antiinflammatory activities in mast cells and different immunomodulatroy effects in B cells and Th cells.

Towards the Application of Human Defensins as Antivirals

  • Park, Mee Sook;Kim, Jin Il;Lee, Ilseob;Park, Sehee;Bae, Joon-Yong;Park, Man-Seong
    • Biomolecules & Therapeutics
    • /
    • 제26권3호
    • /
    • pp.242-254
    • /
    • 2018
  • Defensins are antimicrobial peptides that participate in the innate immunity of hosts. Humans constitutively and/or inducibly express ${\alpha}$- and ${\beta}$-defensins, which are known for their antiviral and antibacterial activities. This review describes the application of human defensins. We discuss the extant experimental results, limited though they are, to consider the potential applicability of human defensins as antiviral agents. Given their antiviral effects, we propose that basic research be conducted on human defensins that focuses on RNA viruses, such as human immunodeficiency virus (HIV), influenza A virus (IAV), respiratory syncytial virus (RSV), and dengue virus (DENV), which are considered serious human pathogens but have posed huge challenges for vaccine development for different reasons. Concerning the prophylactic and therapeutic applications of defensins, we then discuss the applicability of human defensins as antivirals that has been demonstrated in reports using animal models. Finally, we discuss the potential adjuvant-like activity of human defensins and propose an exploration of the 'defensin vaccine' concept to prime the body with a controlled supply of human defensins. In sum, we suggest a conceptual framework to achieve the practical application of human defensins to combat viral infections.